Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome

  title={Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome},
  author={C. J. Bijkerk and Jwm Muris and J. A. Knottnerus and Arno W Hoes and Niek J. de Wit},
  journal={Alimentary Pharmacology \& Therapeutics},
Background : Both high‐fibre dietary advice and the prescription of fibre as a bulking agent are very common in primary and secondary care management of irritable bowel syndrome. Irritable bowel syndrome patients with constipation may have delayed intestinal transit. Therefore, fibres that accelerate intestinal transit may be beneficial in these patients. The uncertain benefits reported in several clinical studies, however, have led us to reappraise the value of fibre in irritable bowel… 

Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome

The concept of augmenting the management of irritable bowel syndrome with antibiotics is evolving, and many questions remain regarding this therapy relative to known and hypothesized irritable bowel

The role of fiber in the treatment of irritable bowel syndrome: therapeutic recommendations.

  • M. Zuckerman
  • Medicine
    Journal of clinical gastroenterology
  • 2006
Although dietary fiber or bulking agents do not appear to be useful as sole treatment of irritable bowel syndrome, they may have a limited role in empiric therapy depending upon the patient's symptom complex, especially if constipation is the most significant symptom.

Management of irritable bowel syndrome with constipation: a flexible approach to treating a complex condition with multiple symptoms

  • P. Layer
  • Medicine
    Expert review of gastroenterology & hepatology
  • 2013
Rational, evidence-based management strategy and treatment options for irritable bowel syndrome are reviewed.

Pathogenesis and management of irritable bowel syndrome.

  • P. MathewS. Bhatia
  • Medicine
    Tropical gastroenterology : official journal of the Digestive Diseases Foundation
  • 2009
The treatment of IBS is targeted at the management of constipation, diarrhoea and abdominal pain and includes pharmacotherapy with tegaserod, alosetron and lubiprostone and Cognitive behavioral therapy is very beneficial.

Irritable bowel syndrome in adults: symptoms, treatment and management.

  • Rhian Sunderland
  • Medicine
    Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • 2017
This article aims to inform readers about the symptoms and sub-classifications of IBS and the range of pharmacological and non-pharmacological treatments available, to enable nurses to understand and manage symptoms of the condition in this group of patients.

Current Strategies in the Management of Irritable Bowel Syndrome

Though this paper focuses on management, a review of pathophysiology and specific guidelines establishing a diagnosis of IBS will be addressed.

Dietary fibre in the management of gastrointestinal symptoms

There is limited evidence to support the use of dietary fibre and fibre supplements in clinical gastroenterology, and there may be conditions where types of fibre may be harmful or exacerbate bowel symptoms.

The role of fiber supplementation in the treatment of irritable bowel syndrome: a systematic review and meta-analysis

Soluble fiber appears to improve symptoms of IBS, whereas there is no evidence for recommending insoluble fiber for IBS.

Preventing constipation: a review of the laxative potential of food ingredients

There are major discrepancies between the proposed fibre-enriched ingredients and the consumers' needs, suggesting that the true impact of dietary fibre and potent food-grade laxatives might also be limited by overeating.

[Irritable bowel syndrome: dietary and pharmacological therapeutic options].

  • P. Ducrotte
  • Medicine
    Gastroenterologie clinique et biologique
  • 2009



Dietary fibre modification and the symptoms of irritable bowel syndrome–a review

It is concluded that no consensus on the efficacy of fibre treatment in IBS can be reached due to variations in methodology employed and the existence of symptom-specific sub-groups of the disorder.

Bran supplementation in the treatment of irritable bowel sgndrome

Patients with irritable bowel syndrome are frequently advised to increase their intake of bran fibre, despite inconclusive experimental evidence of benefit.

Review article: clinical evidence to support current therapies of irritable bowel syndrome

  • M. Camilleri
  • Medicine, Psychology
    Alimentary pharmacology & therapeutics
  • 1999
Current therapies targeted on the predominant symptoms in IBS are moderately successful, and new therapies are needed to more effectively relieve this syndrome, not just symptoms.

The effect of coarse wheat bran in the irritable bowel syndrome. A double-blind cross-over study.

It is concluded that coarse Wheat bran used as the only treatment in IBS does not provide a sufficient effect in a 6-week period, but wheat bran seems to be justified in the treatment of constipation.

Ispaghula therapy in irritable bowel syndrome: Improvement in overall well‐being is related to reduction in bowel dissatisfaction

There was a correlation between the improvement of well‐being and the number of days of satisfying bowel movements but not with the indexes of pain, stool frequency or changes in the transit time, suggesting the easing of bowel dissatisfaction appears to be a major reason for the therapeutic success of ispaghula in IBS.

Diet and irritable bowel syndrome

  • D. Alpers
  • Medicine
    Current opinion in gastroenterology
  • 2006
This review will briefly consider recent findings in food intolerance, food allergy, the effect of intestinal bacterial flora on ingested food, and food ‘sensitivity’ that is not related to physiological intolerance or to true allergy.